Based on data from the past 90 days ending January 09, 2026, Sarepta Therapeutics's three largest insider shareholders are Director Richard Barry (3.11Mn shares), Chief Executive Officer Douglas S Ingram (929.39K shares), Director Michael Andrew Chambers (294.69K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Richard Barry | 3,106,667 | 19 May, 2025 | |
| Douglas S Ingram | Chief Executive Officer | 929,391 | 09 Dec, 2025 |
| Michael Andrew Chambers | 294,694 | 11 Mar, 2025 | |
| Louise Rodino-Klapac | President And R&D And Tech Ops | 224,030 | 19 Nov, 2025 |
| M Kathleen Behrens | 193,476 | 11 Mar, 2025 | |
| Ian Michael Estepan | Chief Operating Officer | 193,300 | 18 Dec, 2025 |
| Cristin Rothfuss | Evp And General Counsel | 139,756 | 02 Dec, 2025 |
| Ryan Ho-Yan Wong | Chief Financial Officer | 136,045 | 10 Dec, 2025 |
| Dallan Murray | Chief Customer Officer | 38,202 | 11 Mar, 2025 |
| Bilal Arif | Chief Tech Ops Officer | 32,500 | 11 Mar, 2025 |
| Claude Nicaise | 27,812 | 13 Mar, 2025 | |
| Hans Lennart Rudolf Wigzell | 25,223 | 11 Mar, 2025 | |
| William Ciambrone | Evp | 22,099 | 08 Mar, 2022 |
| Ryan Edward Brown | Evp And General Counsel | 17,129 | 25 Jun, 2024 |
| Mary Ann Gray | 12,356 | 08 Mar, 2022 | |
| Stephen Mayo | 9,004 | 11 Mar, 2025 | |
| Kathryn Jean Boor | 8,263 | 11 Mar, 2025 | |
| Deirdre P Connelly | 5,225 | 11 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Dec, 2025 | Ian Michael Estepan | Common Stock | D | 13,187 | $22.31 | 193,300 | D | S |
| 07 Dec, 2025 | Douglas S Ingram | Common Stock | A | 50,000 | $0.00 | 440,307 | D | A |
| 07 Dec, 2025 | Douglas S Ingram | Common Stock | A | 269,542 | $0.00 | 929,391 | D | A |
| 07 Dec, 2025 | Douglas S Ingram | Common Stock | A | 50,000 | $0.00 | 490,307 | D | A |
| 07 Dec, 2025 | Douglas S Ingram | Common Stock | A | 73,001 | $0.00 | 563,308 | D | A |
| 07 Dec, 2025 | Douglas S Ingram | Common Stock | A | 96,541 | $0.00 | 659,849 | D | A |
| 01 Dec, 2025 | Ryan Ho-Yan Wong | Common Stock | D | 78 | $20.96 | 136,045 | D | F |
| 01 Dec, 2025 | Ryan Ho-Yan Wong | Common Stock | D | 80 | $20.96 | 136,123 | D | F |
| 28 Nov, 2025 | Cristin Rothfuss | Common Stock | D | 229 | $21.12 | 139,756 | D | F |
| 17 Nov, 2025 | Louise Rodino-Klapac | Common Stock | D | 4,582 | $18.42 | 224,030 | D | F |
| 03 Sep, 2025 | Louise Rodino-Klapac | Common Stock | A | 50,000 | $0.00 | 228,612 | D | A |
| 03 Sep, 2025 | Louise Rodino-Klapac | Common Stock | A | 93,875 | $0.00 | 178,612 | D | A |
| 03 Sep, 2025 | Ian Michael Estepan | Common Stock | A | 50,000 | $0.00 | 206,487 | D | A |
| 03 Sep, 2025 | Ian Michael Estepan | Common Stock | A | 93,875 | $0.00 | 156,487 | D | A |
| 03 Sep, 2025 | Cristin Rothfuss | Common Stock | A | 25,000 | $0.00 | 139,985 | D | A |
| 03 Sep, 2025 | Cristin Rothfuss | Common Stock | A | 93,875 | $0.00 | 114,985 | D | A |
| 03 Sep, 2025 | Ryan Ho-Yan Wong | Common Stock | A | 93,875 | $0.00 | 111,203 | D | A |
| 03 Sep, 2025 | Ryan Ho-Yan Wong | Common Stock | A | 25,000 | $0.00 | 136,203 | D | A |
| 31 Jul, 2025 | Ryan Ho-Yan Wong | Common Stock | D | 327 | $16.42 | 17,328 | D | F |
| 16 May, 2025 | Richard Barry | Common Stock | A | 12,350 | $32.63 | 2,966,667 | D | M |